comparemela.com

Latest Breaking News On - Control cardiovascular risk - Page 5 : comparemela.com

Another Study Shows Fenofibrate Benefit on Diabetic Retinopathy

While a Korean study shows reduction in diabetic retinopathy progression by 11% with fenofibrate plus statin compared with statin alone, some reservations remain over wider use.

United statesSouth koreaSouth koreanThomas nystrNam hoon kimEuropean association for the study of diabetesCohorts from large korean national databaseKorea university college of medicineKarolinska instituteKorea university anam hospitalDrug administrationEuropean associationKorea university collegeDiabetic retinopathy progression lower withStudy findings areControl cardiovascular risk

Remnant Cholesterol Predicts CV risk in T2D

Baseline and follow-up remnant cholesterol levels predict cardiovascular events in patients with type 2 diabetes.

United statesBaylor college of medicinePeter wf wilsonChristiem ballantyneLiyao fuShi taiEmory school of medicineSecond xiangya hospital of central south universityControl cardiovascular riskSecond xiangya hospitalCentral south universityAnalyses support prognostic valueSouth centralBaylor collegeEmory school

Genetic Mapping Predicts Risk of Cardiovascular Events in People With Type 2 Diabetes

Polygenic risk scores are associated with hypertension and predictive of increased risk of adverse CVD events in individuals with T2D.

National institutes of healthNational institutesControl cardiovascular riskPrecision medicine

New study validates predictive biomarkers in diabetic kidney disease, an important step in precision medicine

NaviDKD™ proactive screening technology for kidney health from Journey Biosciences confirmed in type 2 diabetes population. LEBANON, N.H., May 3, .

Paul beisswengerAdam graybillGeisel school of medicine at dartmouthVeterans affairs diabetes trialJourney biosciences incPrnewswire journey biosciences incJourney biosciencesDiabetes careControl cardiovascular riskBiosciences founderChief scientific officerProfessor emeritusGeisel schoolJourney bioscience

Insulin Glargine Recall; Obesity & Endometrial Cancer; Red Light for Testosterone?

News and commentary from the endocrinology world

New yorkUnited statesTucker carlsonJournal of the american college cardiologyMylan pharmaceuticalsDepartment of veterans affairsUs preventive services taskAmerican collegeServices task forceVeterans affairsControl cardiovascular riskDiabetes careNew york city

vimarsana © 2020. All Rights Reserved.